Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Majidinia, Maryam, Rasmi, Yousef, Khadem Ansari, Mohammad Hassan, Seyed-Mohammadzad, MirHossein, Saboory, Ehsan, Shirpoor, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149044/
https://www.ncbi.nlm.nih.gov/pubmed/27980592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149044/
https://www.ncbi.nlm.nih.gov/pubmed/27980592

Ejemplares similares